Clinical Trials Directory

Trials / Completed

CompletedNCT02237612

Diffusion-Weighted MRI in Staging Patients With Localized Prostate Cancer

Diffusion-Weighted MRI for Staging in Localized Prostate Cancer: A Pilot Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
9 (actual)
Sponsor
University of Southern California · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

This pilot clinical trial studies how well diffusion-weighted magnetic resonance imaging (MRI) works in staging patients with prostate cancer that has not spread to nearby lymph nodes or other parts of the body. New imaging techniques, such as diffusion-weighted MRI, may be a less invasive way of predicting the stage and grade of prostate cancer.

Detailed description

PRIMARY OBJECTIVES: I. To determine the sensitivity and specificity of diffusion-weighted MRI for pathologic T3 stage prostate cancer using a 3 Tesla (3T) magnet with a surface coil. OUTLINE: Patients undergo diffusion-weighted MRI of the pelvis.

Conditions

Interventions

TypeNameDescription
PROCEDUREdiffusion-weighted magnetic resonance imagingUndergo diffusion-weighted MRI
OTHERlaboratory biomarker analysisCorrelative studies

Timeline

Start date
2009-01-01
Primary completion
2013-03-01
Completion
2013-03-01
First posted
2014-09-11
Last updated
2014-09-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02237612. Inclusion in this directory is not an endorsement.